Acronym
MoST 10 (substudies 23-24)
Project Title
Single arm, open label, signal seeking, phase II trial of the activity of Palbociclib in combination with Avelumab in patients with tumours with amplified D-type cyclins or CDK4/6 or inactivation of CDKN2A.
Principal Investigator
Start Date
December 11, 2019
Keywords
Cancer/amplified D-type cyclins or CDK4/6 or inactivation of CDKN2A.
Project Type
Interventional/Clinical trials research
NT Health Work Unit
